VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer
Clinical trial NCT06337695 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06337695
- Sponsor
- University of Calgary
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-11-01
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.